ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 39 filers reported holding ANNOVIS BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $464,450 | -92.2% | 48,941 | -88.3% | 0.22% | -91.0% |
Q2 2023 | $5,988,511 | +183.8% | 419,070 | +530.5% | 2.44% | +450.5% |
Q3 2021 | $2,110,000 | -80.5% | 66,469 | -47.4% | 0.44% | -77.2% |
Q2 2021 | $10,824,000 | +249.0% | 126,469 | +7.9% | 1.95% | +198.9% |
Q1 2021 | $3,101,000 | -11.3% | 117,256 | -74.7% | 0.65% | -54.1% |
Q4 2020 | $3,497,000 | – | 463,797 | – | 1.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
Cannell & Co. | 10,000 | $75,000 | 0.00% |
Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |